Welcome to zhongchongxinnuo biotechnology Taizhou Co., Ltd

At present, it has the R & D platform for new biological products of livestock and poultry, quality evaluation platform, vaccine adjuvant technology platform, cell, virus, molecular biological diagnosis and detection technology R & D platform. It has obtained CNAs certificate and is the first CNAs Laboratory for animal vaccine quality evaluation in China. At present, there are 45 CNAs approval test parameters running on the platform, including finished vaccine test, pig disease test and poultry disease test parameters, including sterility test, virus content test, exogenous virus test, efficacy test, plaque count and formaldehyde residue test, which can meet the needs of animal biological products test and epidemic disease monitoring in all aspects.

In 2016, the company, together with Taizhou pharmaceutical Park and Chengdu safety assessment center, established a pre clinical safety assessment center for new drugs, which is mainly engaged in research and development, technology transfer, technology promotion, technical consulting services and product characteristic inspection services of pharmaceutical technology.

　　In 2018, the company and Jiangsu agricultural and animal husbandry vocational and technical college jointly applied for approval to establish the Key Laboratory of agricultural products and livestock inputs safety assessment of the Ministry of agriculture and rural areas.

　　The company has successively undertaken three national key R & D projects, including "integrated and demonstration research on Newcastle disease prevention and control technology in breeding farms", "Research on quality evaluation standard of biological products and testing reagents for animal use", "Research on new technology of Avian Influenza Immune Prevention and control", and presided over the "quality standard of white oil for injection" and "General requirements for raw materials of animal origin" in China veterinary medicine code (2015 version) The revision of several national standards, such as "requirements for the safety inspection of animal vaccines", "viscosity determination method", etc. 8 patents were applied for and 1 was obtained.

Jiangsu Huachuang Xinnuo Pharmaceutical Technology Co., Ltd

　　Jiangsu Huachuang Xinnuo Pharmaceutical Technology Co., Ltd. (CMC drug safety evaluation center) is jointly established by zhongchong Xinnuo biotechnology Taizhou Co., Ltd. and Jiangsu Huachuang pharmaceutical R & D Platform Management Co., Ltd. with a registered capital of 10 million yuan. The national Chengdu new drug safety evaluation center provides technical support. It is a high-tech enterprise specializing in the evaluation and research of the safety and effectiveness of human drugs (chemical drugs, antibodies, biotechnology drugs, new preparations drugs, traditional Chinese medicine, etc.), veterinary drugs, animal vaccines, and technical consulting services.